GlassScriptPhysician profile
Nina F Johnson
NPI 1063407237
$7,454.77
in general payments reported to CMS, 2019-2025
14 companies · $6,708 in 2025
The $6,708 reported for 2025 was more than what 96% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $11.08 · 2023: $97.65 · 2024: $357 · 2025: $6,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,080 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $550 · Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,080.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $550.00 |
| Food and Beverage | $532.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $7,012.71 | 2019-2025 | Tagrisso, Imfinzi |
| Bioprotect Medical, INC. | $102.34 | 2025 | Bioprotect Balloon Implant System |
| Novocure INC. | $75.75 | 2025 | Optune Gio |
| E.R. Squibb & Sons, L.L.C. | $67.95 | 2019 | |
| Astellas Pharma US INC | $43.16 | 2019 | |
| Merck Sharp & Dohme LLC | $24.34 | 2019 | |
| Sanofi Pasteur INC. | $21.53 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $19.97 | 2019 | |
| Celgene Corporation | $17.23 | 2019 | |
| Puma Biotechnology, INC. | $15.51 | 2019 | |
| Seagen INC. | $15.33 | 2019 | |
| Incyte Corporation | $14.72 | 2019 | |
| Genzyme Corporation | $13.15 | 2019 | |
| Accuray Incorporated | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.